
PMC:7795966 / 21425-21665
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
727 | 105-113 | Species | denotes | patients | Tax:9606 |
728 | 231-239 | Species | denotes | patients | Tax:9606 |
733 | 64-82 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
734 | 186-204 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
746 | 90-104 | Disease | denotes | G6PD-deficient | MESH:D005955 |
747 | 209-218 | Disease | denotes | hemolysis | MESH:D006461 |
748 | 222-230 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T170 | 0-240 | Sentence | denotes | Nevertheless, Mastroianni et al. [47] and Afra [48], concerning hydroxychloroquine use in G6PD-deficient patients, have indicated that it is difficult to assess the relationship between hydroxychloroquine and hemolysis in COVID-19 patients. |